* Alimera Sciences Inc ALIM.OQ ALIM.O is expected
to show a
fall in quarterly revenue when it reports results on February
24.
* The Alpharetta Georgia-based company is expected to
report a
2.7% decrease in revenue to $13.405 million from $13.77 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Alimera Sciences
Inc is
for a loss of 42 cents per share. For the same quarter last
year, the company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $14.5, about 67.9% above its last closing price
of $4.65.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.52 -0.52 -0.60 Missed -14.3
Jun. 30 2021 1.05 1.06 0.72 Missed -32.1
Mar. 31 2021 -0.52 -0.54 -0.63 Missed -16.7
Dec. 31 2020 -0.04 -0.04 -0.18 Missed -315.4
Sep. -0.44 -0.44 -0.12 Beat 72.9
30 2020
Jun. 30 2020 -1.09 -1.61 -0.51 Beat 68.4
Mar. 31 2020 -0.44 -0.43 -0.24 Beat 44.5
Dec. 31 2019 -0.35 -0.45 0.08 Beat 117.7
This summary was machine generated February 22 at 19:34 GMT.
All figures in US dollars unless otherwise stated